Clinical Trial Update: Emulation of the REWIND Cardiovascular Outcomes Trial in Healthcare Claims Data.

View source ↗

Summary

A study to emulate the REWIND cardiovascular outcomes trial using healthcare claims data to evaluate dulaglutide in individuals with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• TRULICITY (DULAGLUTIDE)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Type 2 Diabetes | Status: ACTIVE_NOT_RECRUITING